Samjin Pharm (005500) — Cash Flow Quality Index
Samjin Pharm (005500) has a Cash Flow Quality Index of -0.21x as of September 2025. Operating cash flow of ₩-1.43 Billion is below net income of ₩6.84 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Samjin Pharm operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Samjin Pharm Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Samjin Pharm across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 005500 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Samjin Pharm (2013–2024)
Year-by-year earnings quality comparison for Samjin Pharm. For live market cap and the full company financial profile, see market cap of Samjin Pharm.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.97x | ₩38.15 Billion | ₩39.23 Billion | ▲ +120.6% |
| 2023 | 0.44x | ₩8.33 Billion | ₩18.91 Billion | ▼ -44.2% |
| 2022 | 0.79x | ₩17.29 Billion | ₩21.89 Billion | ▼ -6.4% |
| 2021 | 0.84x | ₩23.97 Billion | ₩28.40 Billion | ▼ -1.4% |
| 2020 | 0.86x | ₩23.86 Billion | ₩27.88 Billion | ▼ -57.0% |
| 2019 | 1.99x | ₩23.63 Billion | ₩11.88 Billion | ▲ +68.8% |
| 2018 | 1.18x | ₩30.08 Billion | ₩25.53 Billion | ▲ +13.1% |
| 2017 | 1.04x | ₩37.28 Billion | ₩35.80 Billion | ▼ -35.4% |
| 2016 | 1.61x | ₩48.66 Billion | ₩30.17 Billion | ▲ +130.3% |
| 2015 | 0.70x | ₩18.94 Billion | ₩27.04 Billion | ▼ -55.2% |
| 2014 | 1.56x | ₩32.41 Billion | ₩20.72 Billion | ▲ +67.1% |
| 2013 | 0.94x | ₩7.37 Billion | ₩7.88 Billion | — |